FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Transcatheter Septal Occluder
PMA: P120021
·
Supplement: S020
·
Decision Sep 27, 2021
Classifications
1
FEI Numbers
11
Registration Numbers
11
Basic Information
- Device Name
- Transcatheter Septal Occluder
- Trade Name
- Amplatzer Talisman PFO Occluder
- PMA Number
- P120021
- Supplement Number
- S020
- Device Class
- FDA Class 3
- Product Code
- MLV
- Generic Name
- Transcatheter septal occluder
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- September 27, 2021
- Date Received
- April 1, 2021
- Supplement Type
- Normal 180 Day Track
- Supplement Reason
- Change Design/Components/Specifications/Material
- Expedited Review
- N
Advisory Committee Statement
Approval for the Amplatzer Talisman PFO Occluder (Talisman PFO); a line extension of the current Amplatzer PFO Occluder (PFO) product family.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MLV | Transcatheter Septal Occluder | FDA class 3 | Unknown |